Sintx Technologies (SINT) Competitors

Sintx Technologies logo
$1.22 -0.12 (-8.96%)
Closing price 11/17/2026 03:55 PM Eastern
Extended Trading
$1.34 +0.12 (+9.84%)
As of 09:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SINT vs. TELA, QTEX, IINN, ELUT, and NSPR

Should you buy Sintx Technologies stock or one of its competitors? Sintx Technologies's main competitors and comparable companies include TELA Bio (TELA), QTREX Quantum (QTEX), Inspira Technologies OXY B.H.N. (IINN), Elutia (ELUT), and InspireMD (NSPR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sintx Technologies compare to TELA Bio?

TELA Bio (NASDAQ:TELA) and Sintx Technologies (NASDAQ:SINT) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

TELA Bio currently has a consensus price target of $2.14, indicating a potential upside of 181.18%. Sintx Technologies has a consensus price target of $9.50, indicating a potential upside of 678.69%. Given Sintx Technologies' higher possible upside, analysts plainly believe Sintx Technologies is more favorable than TELA Bio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

94.4% of TELA Bio shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 1.1% of TELA Bio shares are held by company insiders. Comparatively, 8.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Sintx Technologies had 1 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Sintx Technologies and 2 mentions for TELA Bio. Sintx Technologies' average media sentiment score of 0.53 beat TELA Bio's score of 0.48 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TELA Bio
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sintx Technologies
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sintx Technologies has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$80.28M0.35-$38.83M-$0.74N/A
Sintx Technologies$1.02M9.04-$10.36M-$1.69N/A

TELA Bio has a net margin of -53.57% compared to Sintx Technologies' net margin of -281.91%. Sintx Technologies' return on equity of -309.86% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-53.57% -1,320.81% -60.17%
Sintx Technologies -281.91%-309.86%-101.90%

Summary

Sintx Technologies beats TELA Bio on 7 of the 13 factors compared between the two stocks.

How does Sintx Technologies compare to QTREX Quantum?

QTREX Quantum (NASDAQ:QTEX) and Sintx Technologies (NASDAQ:SINT) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Sintx Technologies has a consensus price target of $9.50, indicating a potential upside of 678.69%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than QTREX Quantum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QTREX Quantum
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

12.7% of QTREX Quantum shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 29.4% of QTREX Quantum shares are held by company insiders. Comparatively, 8.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, QTREX Quantum and QTREX Quantum both had 3 articles in the media. QTREX Quantum's average media sentiment score of 0.73 beat Sintx Technologies' score of 0.53 indicating that QTREX Quantum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QTREX Quantum
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sintx Technologies
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sintx Technologies has higher revenue and earnings than QTREX Quantum.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QTREX Quantum$290K135.12-$13.22MN/AN/A
Sintx Technologies$1.02M9.04-$10.36M-$1.69N/A

QTREX Quantum has a net margin of 0.00% compared to Sintx Technologies' net margin of -281.91%. QTREX Quantum's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
QTREX QuantumN/A N/A N/A
Sintx Technologies -281.91%-309.86%-101.90%

Summary

QTREX Quantum and Sintx Technologies tied by winning 6 of the 12 factors compared between the two stocks.

How does Sintx Technologies compare to Inspira Technologies OXY B.H.N.?

Sintx Technologies (NASDAQ:SINT) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

Sintx Technologies has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sintx Technologies$1.02M9.04-$10.36M-$1.69N/A
Inspira Technologies OXY B.H.N.$289K143.05-$13.22MN/AN/A

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 8.1% of Sintx Technologies shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Sintx Technologies' net margin of -281.91%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sintx Technologies-281.91% -309.86% -101.90%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Sintx Technologies currently has a consensus target price of $9.50, suggesting a potential upside of 678.69%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Sintx Technologies and Sintx Technologies both had 3 articles in the media. Sintx Technologies' average media sentiment score of 0.53 beat Inspira Technologies OXY B.H.N.'s score of 0.22 indicating that Sintx Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sintx Technologies
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Sintx Technologies beats Inspira Technologies OXY B.H.N. on 7 of the 12 factors compared between the two stocks.

How does Sintx Technologies compare to Elutia?

Elutia (NASDAQ:ELUT) and Sintx Technologies (NASDAQ:SINT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

Elutia has higher revenue and earnings than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than Elutia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elutia$12.29M3.08$53.38M$1.110.77
Sintx Technologies$1.02M9.04-$10.36M-$1.69N/A

74.0% of Elutia shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 17.8% of Elutia shares are owned by insiders. Comparatively, 8.1% of Sintx Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Sintx Technologies had 1 more articles in the media than Elutia. MarketBeat recorded 3 mentions for Sintx Technologies and 2 mentions for Elutia. Sintx Technologies' average media sentiment score of 0.53 beat Elutia's score of -0.18 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elutia
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Sintx Technologies
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sintx Technologies has a consensus price target of $9.50, suggesting a potential upside of 678.69%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Sintx Technologies is more favorable than Elutia.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elutia
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Elutia has a net margin of 546.70% compared to Sintx Technologies' net margin of -281.91%. Elutia's return on equity of -140.53% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Elutia546.70% -140.53% -54.54%
Sintx Technologies -281.91%-309.86%-101.90%

Summary

Elutia beats Sintx Technologies on 8 of the 14 factors compared between the two stocks.

How does Sintx Technologies compare to InspireMD?

Sintx Technologies (NASDAQ:SINT) and InspireMD (NYSE:NSPR) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 8.1% of Sintx Technologies shares are held by insiders. Comparatively, 25.0% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Sintx Technologies currently has a consensus target price of $9.50, indicating a potential upside of 678.69%. InspireMD has a consensus target price of $4.50, indicating a potential upside of 592.31%. Given Sintx Technologies' higher possible upside, equities analysts plainly believe Sintx Technologies is more favorable than InspireMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
InspireMD
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Sintx Technologies has higher earnings, but lower revenue than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sintx Technologies$1.02M9.04-$10.36M-$1.69N/A
InspireMD$10.84M2.79-$19.92M-$0.59N/A

In the previous week, InspireMD had 10 more articles in the media than Sintx Technologies. MarketBeat recorded 13 mentions for InspireMD and 3 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.53 beat InspireMD's score of 0.46 indicating that Sintx Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sintx Technologies
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
InspireMD
3 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sintx Technologies has a net margin of -281.91% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sintx Technologies-281.91% -309.86% -101.90%
InspireMD -413.96%-69.42%-57.68%

Summary

InspireMD beats Sintx Technologies on 8 of the 13 factors compared between the two stocks.

Get Sintx Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SINT vs. The Competition

MetricSintx TechnologiesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$10.13M$5.99B$7.83B$11.74B
Dividend YieldN/A1.68%2.47%4.47%
P/E RatioN/A38.0633.9728.44
Price / Sales9.045.398.495.70
Price / CashN/A23.6221.0121.90
Price / Book2.714.174.453.72
Net Income-$10.36M$143.92M$3.52B$393.10M
7 Day Performance-24.69%-5.44%-5.94%-5.77%
1 Month Performance-29.89%-3.64%-4.58%-7.14%
1 Year Performance-63.03%-0.05%-1.95%-7.47%

Sintx Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SINT
Sintx Technologies
2.9432 of 5 stars
$1.22
-9.0%
$9.50
+678.7%
-65.0%$10.13M$1.02MN/A32
TELA
TELA Bio
3.1416 of 5 stars
$0.80
-7.5%
$2.14
+167.9%
-33.1%$39.03M$80.28MN/A218
QTEX
QTREX Quantum
1.5533 of 5 stars
$1.02
-3.8%
N/AN/A$38.11M$290KN/A41
IINN
Inspira Technologies OXY B.H.N.
0.0673 of 5 stars
$1.06
+2.9%
N/A+25.1%$38.11M$289KN/A20
ELUT
Elutia
0.8244 of 5 stars
$0.93
+11.6%
N/A+16.9%$37.02M$12.29MN/A26

Related Companies and Tools


This page (NASDAQ:SINT) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners